Data / Form D filings / MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc.: Form D filings
MapLight Therapeutics, Inc., a biotechnology company in Redwood City, CA, filed 8 Form D notices with the SEC between 2019 and 2025. The latest, on July 28, 2025, reports $188.2 million sold of a $372.4 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 800 CHESAPEAKE DRIVE, Redwood City, CA, 94063
- Phone
- (650) 839-4360
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1770069
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | New notice | $372,449,989 | $188,187,915 | $184,262,074 | 19 | Jul 18, 2025 | sec.gov |
| Nov 3, 2023 | Amendment | $224,999,980 | $104,999,994 | $119,999,986 | 12 | Jul 5, 2023 | sec.gov |
| Jul 19, 2023 | New notice | $174,999,988 | $49,999,997 | $124,999,991 | 5 | Jul 5, 2023 | sec.gov |
| Nov 10, 2022 | New notice | $11,999,999 | $11,999,999 | 1 | Oct 25, 2022 | sec.gov | |
| Mar 10, 2021 | New notice | $59,999,999 | $29,999,999 | $30,000,000 | 2 | Feb 23, 2021 | sec.gov |
| Sep 4, 2019 | New notice | $15,999,999 | $15,999,999 | 2 | Aug 23, 2019 | sec.gov | |
| Mar 22, 2019 | Amendment | $5,000,000 | $5,000,000 | 2 | Feb 22, 2019 | sec.gov | |
| Mar 8, 2019 | New notice | $5,000,000 | $5,000,000 | 2 | Feb 22, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kristopher A Hanson | Executive Officer | |
| Timothy A Garnett | Director | |
| George A Pavlov | Director | |
| Peter A Bisgaard | Director | |
| Erin A Foff | Executive Officer | |
| Anatol A Kreitzer | Executive Officer | |
| Jim A Trenkle | Director | |
| James A Lillie | Executive Officer | |
| Maria A Walker | Director | |
| Christopher A Kroeger | Executive Officer, Director | |
| Jonathan A Gillis | Executive Officer | |
| Vishwas A Setia | Executive Officer | |
| Nanna A Luneborg | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 28, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MapLight Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.